In fact, a meta-analysis of fourteen studies, involving 2326 solid cancer patients, has recently revealed that high GAL9 expression was associated to improved overall survival, and was significantly correlated with smaller depth of invasion, earlier histopathological stage, negative lymph node metastasis and negative distal tumor metastasis [26]. The gene discussed is LGALS9; the disease is neoplasm.